Pharmabiz

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Investigational New Drug (IND) by the Center for Drug ...
Pharmabiz

Ginkgo Bioworks and Carnegie-Mellon University partner to develop innovative new cancer screening approach

Ginkgo Bioworks, a company builds the tools that make biology easier to engineer for everyone, announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research ...
Pharmabiz

Australia and Indonesia achieve WHO Listed Authority status in medical products regulation

The World Health Organization (WHO) has formally recognized the regulatory authorities for medical products of Australia and Indonesia as WHO Listed Authorities (WLAs), an achievement that underscores ...
Pharmabiz

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:40 Hrs [IST] As World Constipation ...
Pharmabiz

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:50 Hrs [IST] Emcure P ...
Pharmabiz

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:30 Hrs [IST] Sharda Hospital has become ...
Pharmabiz

NIT Rourkela bags SPARC project of Rs. 95.16 lakh for research on wearable robotic devices: Exoskeletons

NIT Rourkela bags SPARC project of Rs. 95.16 lakh for research on wearable robotic devices: Exoskeletons: Our Bureau, Bengaluru Wednesday, December 24, 2025, 14:40 Hrs [IST] Natio ...
Pharmabiz

Care ADHD expands set up its 1st Global Capability Centre in India

Care ADHD expands set up its 1st Global Capability Centre in India: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:15 Hrs [IST] Care ADHD, one of the United Kingdom’s fa ...
Pharmabiz

Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval

Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval: Incheon, Korea Wednesday, December 24, 2025, 15:00 Hrs [IST] Samsung Bioepis Co., Ltd., a biopharma ...
Pharmabiz

Saarathi acquisition by QMS to create a unified product-plus-services ecosystem for hospitals, pharma cos

Saarathi acquisition by QMS to create a unified product-plus-services ecosystem for hospitals, pharma cos: Shardul Nautiyal, Mumbai Wednesday, December 24, 2025, 15:45 Hrs [IST] Q ...
Pharmabiz

Faridabad court sentences chemist to three years rigorous imprisonment for unlicensed drug sales

Faridabad court sentences chemist to three years rigorous imprisonment for unlicensed drug sales: Peethaambaran Kunnathoor, Chennai Wednesday, December 24, 2025, 13:15 Hrs [IST] I ...
Pharmabiz

WHO publishes new global analysis revealing major equity gaps in human genomics research

WHO publishes new global analysis revealing major equity gaps in human genomics research: Geneva Wednesday, December 24, 2025, 13:00 Hrs [IST] The World Health Organization (WHO) ...